Description
Administrar por vía intravenosa tras reconstitución
OHRENCIA 125 MG/ML | Solución Inyectable | 4 Jeringas Prellenadas | Bristol-Myers Squibb
AbbVie Inc
Contraindicado en embarazo y lactancia
PRINCIPIO ACTIVO: CLORURO DE ALUMINIO
FOSFOCIL 500 MG 1 AMP JANSSEN MED Administrar por vía intravenosa trasPRINCIPIO ACTIVO: FOSFOMICINA TROMETAMINA DOSIS: 0. 5 G FORMA FARMACUTICA: 1 INYECCION PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
